U.S. Market Projected to Hit USD 7.06 Billion by 2035 While Europe Market Expected to Reach USD 6.42 Billion as Aging Male Population Fuels Demand for Advanced BPH Therapies.Austin, United States, May ...
The Society of Interventional Radiology (SIR) has published new practice guidance for the use of prostatic artery ...
Teleflex (NYSE:TFX) has released new clinical data on its UroLift System for benign prostatic hyperplasia and Barrigel rectal spacer for prostate cancer care. The data, presented at recent urological ...
Prostate health is vital for men over fifty as conditions like BPH, prostatitis, and cancer can affect urinary function and ...
The Society of Interventional Radiology (SIR) published a new practice guidance on prostate artery embolization (PAE) for the ...
Both robot-assisted simple prostatectomy (RASP) and laser enucleation of the prostate (LEP) are safe and effective surgical options for large-volume benign prostatic hyperplasia (BPH), according to a ...
Contemporary diagnosis of very low risk prostate cancer in a multi-centered hospital system. Use of the Prostatype P-score to predict adverse pathology (AP) at radical prostatectomy (RP). This is an ...
An enlarged prostate—also known as benign prostatic hyperplasia (BPH)—is a natural sign of aging that affects half of all men over the age of 40. The good news is this condition does not increase your ...